Literature DB >> 21370246

Ulva rigida improves carbohydrate metabolism, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.

Sibel Tas1, Serap Celikler, Sedef Ziyanok-Ayvalik, Emre Sarandol, Melahat Dirican.   

Abstract

This study was designed to investigate the effects of Ulva rigida, one of the green algae, on the lipid profile and oxidative-antioxidative systems in streptozotocin-induced diabetic rats. Forty Wistar rats randomly divided into four groups: control (C), control + U. rigida extract (C + URE), diabetes (D) and diabetes + U. rigida extract (D + URE). U. rigida (2%) was administered in drinking water for 5 weeks after the induction of diabetes. U. rigida reduced the blood glucose, serum total cholesterol, triglyceride levels and plasma and tissue malondialdehyde (MDA) levels in the D + URE group. Insulin levels were significantly higher in the D + URE than those of the D group. Serum total cholesterol and tissue MDA levels were reduced in the C + URE group. Whole blood glutathione peroxidase and erythrocyte superoxide dismutase activities were higher in the D and C + URE groups compared with the C group. Paraoxonase and arylesterase activities were lower in the D group while U. rigida increased paraoxonase activities in C + URE and D + URE groups. This is the first study which showed U. rigida has antidiabetic and antihyperlipidemic effects and improves oxidative stress in diabetic rats. We conclude that U. rigida might have a potential use as a protective and/or therapeutic agent in diabetes mellitus.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370246     DOI: 10.1002/cbf.1729

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  3 in total

1.  Vitamin B6 supplementation improves oxidative stress and enhances serum paraoxonase/arylesterase activities in streptozotocin-induced diabetic rats.

Authors:  Sibel Taş; Emre Sarandöl; Melahat Dirican
Journal:  ScientificWorldJournal       Date:  2014-11-06

2.  Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide.

Authors:  Lauren A Roach; Barbara J Meyer; J Helen Fitton; Pia Winberg
Journal:  Mar Drugs       Date:  2022-08-02       Impact factor: 6.085

Review 3.  Marine Algae-Derived Bioactive Compounds: A New Wave of Nanodrugs?

Authors:  Farid Menaa; Udari Wijesinghe; Gobika Thiripuranathar; Norah A Althobaiti; Aishah E Albalawi; Barkat Ali Khan; Bouzid Menaa
Journal:  Mar Drugs       Date:  2021-08-26       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.